Chanrx Corp. moved a step closer to the goal line for lead candidate vanoxerine (GBR-12909), reporting Phase IIb data at the American Heart Association (AHA) 2013 Scientific Sessions suggesting the ...
September 22, 2003 — Further investigation aimed at improving efficacy and safety of anticoagulant treatment prior to direct current cardioversion (DCC) for restoration of atrial fibrillation (AF) is ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果